CPSA 2012

Transforming Drug Discovery & Development Through Innovation:
Past, Present and Future

October 1 - 4, 2012
Langhorne, PA

Make plans to attend the 15th Annual Symposium on Clinical & Pharmaceutical Solutions through Analysis (CPSA 2012). This unique event is highly interactive. The program features updated perspectives and experiences on chemical and pharmaceutical structure analysis. Imagination and stimulating discussion are central to each CPSA function and session.

Lisa A. Shipley
Plenary Lecturer

Joanna Pols
2012 Program Chair

2012 Program Chair

Joanna Pols, Merck

Plenary Lecturer

Lisa A. Shipley, Merck

CPSA Background and History

This annual meeting began in 1998 and was the first industry-led event to complement academic-based meetings and address the specific needs of industry researchers. The program highlights current industry trends and relevant topics. The broad-based support has allowed the meeting to evolve into a premier industry-led event that is dedicated to promoting awareness of issues and needs associated with research and development.

Over the past 15 years, the CPSA event has attracted sponsors, thought leaders, and participants who are dedicated to the spirit of cooperation to achieve common goals. The event is dedicated to promoting the analytical sciences in an interactive and educational environment.

Meeting Format

The meeting features a unique format to allow scientists to openly share their comprehensive perspectives on industry-related issues and needs. First-hand experiences with specific applications and technologies are openly discussed.

Symposia Feature - Industry Opinion Leaders

Issues and Needs · Analysis Strategies · Performance Benchmarks

Roundtables Feature - Open Discussion

Commercial Technology · Mainstream Applications · Analysis Trends

Short Courses Feature

Practical Industry Applications · Fundamentals
Real-World Examples · Emerging Methods and Techniques

CPSA attracts sponsors, thought leaders, and participants who are dedicated to the spirit of cooperation to achieve common goals. Imagination needed.

Program Overview

Monday, October 1

Short Courses
Workshop-style courses that focus on specialized training and current industry benchmarks, practices and preferences

Method Development for LC/MS: Traditional Approaches and Emerging Trends
Roger Hayes, MPI Research; Shane Needham, Alturas Analytics
Targeted Metabolomics: The Art & Science of Measuring Drug Efficacy
Mark Hayward, Active Ingredient Technologies; Ken Lewis, OpAns
Assessment of Oral Bioavailability in Preclinical Species and Human: Impact of Physicochemical, Biopharmaceutical and Physiological Factor
Ayman El-Kattan, Pfizer
Analysis of Peptides and Proteins: Sample Preparation to Identification and Quantitation
Nalini Sadagopan, Agilent Technologies; Gary Valaskovic, New Objective; Nathan Yates, University of Pittsburgh
Self Innovation
Lucinda Cohen, Merck

CPSA Open Golf Outing

Sponsors Dinner Event

Tuesday, October 2

Plenary Lecture
Lisa A. Shipley, Merck

Symposia and Roundtables